| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4585948
Max Phase: Preclinical
Molecular Formula: C22H27Cl2N5OS
Molecular Weight: 444.00
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: Cc1cc(C)c2c(N)c(C(=O)NCCc3ccc(N4CCNCC4)c(Cl)c3)sc2n1.Cl
Standard InChI: InChI=1S/C22H26ClN5OS.ClH/c1-13-11-14(2)27-22-18(13)19(24)20(30-22)21(29)26-6-5-15-3-4-17(16(23)12-15)28-9-7-25-8-10-28;/h3-4,11-12,25H,5-10,24H2,1-2H3,(H,26,29);1H
Standard InChI Key: CQZMGNJHVMJEIC-UHFFFAOYSA-N
Associated Targets(Human)
Ubiquitin carboxyl-terminal hydrolase 28 268 Activities
Ubiquitin carboxyl-terminal hydrolase 25 268 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 444.00 | Molecular Weight (Monoisotopic): 443.1547 | AlogP: 3.53 | #Rotatable Bonds: 5 |
| Polar Surface Area: 83.28 | Molecular Species: BASE | HBA: 6 | HBD: 3 |
| #RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 8.83 | CX LogP: 3.86 | CX LogD: 2.42 |
| Aromatic Rings: 3 | Heavy Atoms: 30 | QED Weighted: 0.56 | Np Likeness Score: -1.78 |
References
| 1. (2017) Thienopyridine carboxamides as ubiquitin-specific protease inhibitors, |
Source
Source(1):